EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

An orthotopic prostate cancer model for new treatment development using syngeneic or patient‐derived tumors

Naz Chaudary iD, E Wiljer, Warren Foltz, Pratibha Thapa, Richard P Hill, Michael Milosevic

The Prostate · 2024

DOI: 10.1002/pros.24701 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Prostate, 2024. Verfasst von Naz Chaudary und 5 weiteren Autor:innen. Beteiligte Einrichtung: Princess Margaret Cancer Centre, Toronto, Canada. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Adenocarcinoma, Disease Models, Animal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: This work was supported by grants from the Terry Fox Research Institute (Terry Fox New Frontier Program Project Grants #20005 and #1036) and by the Princess Ma….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

There are limited preclinical orthotopic prostate cancer models due to the technical complexity of surgical engraftment and tracking the tumor growth in the mouse prostate gland. Orthotopic xenografts recapitulate the tumor microenvironment, tumor stromal interactions, and clinical behavior to a greater extent than xenografts grown at subcutaneous or intramuscular sites.

Methods

This study describes a novel micro‐surgical technique for orthotopically implanting intact tumors pieces from cell line derived (transgenic adenocarcinoma mouse prostate [TRAMP]‐C2) or patient derived (neuroendocrine prostate cancer [NEPC]) tumors in the mouse prostate gland and monitoring tumor growth using magnetic resonance (MR) imaging.

Results

The TRAMP‐C2 tumors grew rapidly to a predetermined endpoint size of 10 mm within 3 weeks, whereas the NEPC tumors grew at a slower rate over 7 weeks. The tumors were readily detected by MR and confidently identified when they were approximately 2–3 mm in size. The tumors were less well‐defined on CT. The TRAMP‐C2 tumors were characterized by amorphous sheets of poorly differentiated cells similar to a high‐grade prostatic adenocarcinoma and frequent macroscopic peritoneal and lymph node metastases. In contrast, the NEPC's displayed a neuroendocrine morphology with polygonal cells arranged in nests and solid sheets and high count. There was a local invasion of the bladder and other adjacent tissues but no identifiable metastases. The TRAMP‐C2 tumors were more hypoxic than the NEPC tumors.

Conclusions

This novel preclinical orthotopic prostate cancer mouse model is suitable for either syngeneic or patient derived tumors and will be effective in developing and advancing the current selection of treatments for patients with prostate cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsAdenocarcinomaDisease Models, AnimalAnimalsMaleMiceHumansCell Line, TumorMice, TransgenicNeoplasm TransplantationMagnetic Resonance ImagingCarcinoma, Neuroendocrine

Stichwörter der Autor:innen

orthotopic tumor modelprostate cancer

Autor:innen und Institutionen

  • Princess Margaret Cancer Centre, Toronto, Canada.
  • Department of Radiation Oncology, University of Toronto, Toronto, Canada.
  • Department of Medical Biophysics, University of Toronto, Toronto, Canada.
  • Institute of Medical Science, University of Toronto, Toronto, Canada.

ORCID-Profile: Naz Chaudary

Förderung

  • This work was supported by grants from the Terry Fox Research Institute (Terry Fox New Frontier Program Project Grants #20005 and #1036) and by the Princess Ma…

Zitieren

APA

Chaudary, N., Wiljer, E., Foltz, W., Thapa, P., Hill, R. P., & Milosevic, M. (2024). An orthotopic prostate cancer model for new treatment development using syngeneic or patient‐derived tumors. The Prostate. https://doi.org/10.1002/pros.24701

Vancouver

Chaudary N, Wiljer E, Foltz W, Thapa P, Hill RP, Milosevic M. An orthotopic prostate cancer model for new treatment development using syngeneic or patient‐derived tumors. The Prostate. 2024. doi:10.1002/pros.24701

BibTeX
@article{Chaudary2024,
  author = {Chaudary, Naz and Wiljer, E and Foltz, Warren and Thapa, Pratibha and Hill, Richard P and Milosevic, Michael},
  title = {An orthotopic prostate cancer model for new treatment development using syngeneic or patient‐derived tumors},
  journal = {The Prostate},
  year = {2024},
  doi = {10.1002/pros.24701}
}
Kostenlos starten →